NCT05920148

Brief Summary

The goal of this observational study is to determine changes in immune functioning after total knee replacement surgery in elderly. The study population consists of 14 patients aged 65 years or over undergoing primary total knee replacement surgery. Immune functioning will be assessed at multiple timepoints before and after surgery (i.e., ± 6 weeks before, and 1 day, 1 week, ± 2 weeks, and ± 6 weeks after surgery). Each patient will serve as his/her own control. Immune functioning will primarily be assessed by determining the change from baseline in monocyte-derived TNFα production at 1 week after surgery. Changes in monocyte responsiveness are considered indicative for changes in immune functioning. As secondary objective, additional parameters of immune functioning will be assessed. In addition, the course of immune functioning following total knee replacement surgery will be investigated. Burden and potential risks for the patient are estimated to be minor. During the study, 5 blood samples of 20 mL will be collected over a period of ± 12 weeks, resulting in a total blood draw of 100 mL. During surgery a sample of synovial fluid (± 2 mL) will be taken from surgical waste. Before and after surgery patients will report their pain medication intake and the presence of cold and flu-like symptoms in a diary. Patients do not directly benefit from the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

March 12, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2024

Completed
Last Updated

March 4, 2025

Status Verified

June 1, 2024

Enrollment Period

9 months

First QC Date

June 15, 2023

Last Update Submit

February 27, 2025

Conditions

Keywords

Knee arthroplastyElderlyImmune functioningMonocytes

Outcome Measures

Primary Outcomes (1)

  • Monocyte-derived TNFa production

    TNFα production after ex vivo stimulation of whole blood with inflammatory stimuli corrected for monocyte count

    Change from baseline at 1 week after surgery

Secondary Outcomes (30)

  • Monocyte-derived cytokine production

    Change from baseline at 1 day after surgery

  • Monocyte-derived cytokine production

    Change from baseline at 1 week after surgery

  • Monocyte-derived cytokine production

    Change from baseline at ± 2 weeks after surgery

  • Monocyte-derived cytokine production

    Change from baseline at ± 6 weeks after surgery

  • Monocyte-derived cytokine production

    Change from baseline at 1 day after surgery

  • +25 more secondary outcomes

Other Outcomes (16)

  • Body Mass Index

    Baseline

  • American Society of Anesthesiologists (ASA) classification

    Baseline

  • Kellgren-Lawrence classification

    Baseline

  • +13 more other outcomes

Study Arms (1)

Elderly

Procedure: Knee arthroplasty

Interventions

At multiple timepoints (i.e., ± 6 weeks before, and 1 day, 1 week, ± 2 weeks, and ± 6 weeks after surgery) before and after total knee replacement surgery blood will be collected to assess immune functioning

Elderly

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of 14 patients (classified as ASA II or ASA III) aged 65 years or over, diagnosed with osteoarthritis, undergoing primary total knee replacement surgery.

You may qualify if:

  • Planned for primary total knee replacement surgery
  • Aged 65 years or over
  • Diagnosed with osteoarthritis
  • ASA Physical Status Classification of II or III
  • Willing to donate a blood sample at 5 different timepoints
  • Able to give written informed consent

You may not qualify if:

  • Use of systemic corticosteroids
  • Current diagnosis of cancer
  • Diagnosed with a primary immunodeficiency disorder (e.g., Severe Combined Immunodeficiency (SCID), Common Variable Immune Deficiency (CVID), X-linked agammaglobulinemia, selective immunoglobulin A deficiency, chronic granulomatous disease)
  • Current participation in other scientific research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gelderse Vallei Hospital

Ede, 6716 RP, Netherlands

Location

MeSH Terms

Interventions

Arthroplasty, Replacement, Knee

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator / Associate Professor

Study Record Dates

First Submitted

June 15, 2023

First Posted

June 27, 2023

Study Start

March 12, 2024

Primary Completion

December 11, 2024

Study Completion

December 11, 2024

Last Updated

March 4, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations